Key result
A patient with antithrombin-III deficiency exhibited a diminished anticoagulant response to heparin during cardiopulmonary bypass, highlighting implications for managing heparin rebound.
Population
A patient with antithrombin-III (AT-III) deficiency undergoing cardiopulmonary bypass
Design
Case_report
Authors
Loading...
Clinicians should consider AT-III deficiency in unexplained heparin resistance during CPB; single case leaves open whether monitoring or supplementation improves outcomes.
Case Report (n=1)
Highlights the clinical evaluation and management of AT-III deficiency manifesting as heparin resistance during cardiopulmonary bypass.
Soloway et al. (1980) conducted a case report in Antithrombin-III (AT-III) deficiency (n=1). Heparin was evaluated on Anticoagulant effect. A patient with antithrombin-III deficiency exhibited a diminished anticoagulant response to heparin during cardiopulmonary bypass, highlighting implications for managing heparin rebound.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: